Skip to content

A Prospective Study on TheManagement of Hypertension in Young and Middle-aged Subjects in Enterprises Setting

A Prospective Study on TheManagement of Hypertension in Young and Middle-aged Subjects in Enterprises Setting

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04135911
Acronym
PROMISE
Enrollment
2000
Registered
2019-10-23
Start date
2019-12-30
Completion date
2026-03-31
Last updated
2025-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Hypertension

Brief summary

In recent years, with the investment from government in the health management of the elderly, community management of hypertension in the elderly has made great progress in management rate and standardized management, but the management of young and middle-aged patients with hypertension is still blank. Workplace pressure measurement may be more suitable for most of the young and middle-aged patients to find high blood pressure and monitor blood pressure changes in time. However, there is not much research on workplace pressure measurement. Whether blood pressure measurement in the workplace can reduce the white coat effect, and how it relates to home blood pressure and ambulatory blood pressure is still unclear.

Interventions

None listed

Sponsors

Yan Li
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Male and female sex, aged 18-65 years 2. Three different daytime workplace blood pressure measurements meet the limits: systolic blood pressure ≥ 120 mmHg, or diastolic blood pressure ≥80 mmHg 3. Hypertensive patients who are taking antihypertensive drugs 4. Willing to provide information about disease history and lifestyle 5. Willing to receive follow-up for up to 2-3 years 6. Sign the informed consent

Exclusion criteria

1. Having the onset of cardiovascular and cerebrovascular diseases such as stroke, myocardial infarction or heart failure within 6 months 2. Having a history of atrial fibrillation or frequent arrhythmia 3. Complicating other diseases that are not suitable for the trial, such as thyroid disease with active medication, acute infectious diseases, chronic mental illness, and tumors 4. The subject is participating in other clinical studies.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic classification in hypertension2 yearsDifferences in diagnostic classification between workplace blood pressure and daytime ambulatory blood pressure in the classification of hypertension (masked hypertension or white coat hypertension)

Secondary

MeasureTime frameDescription
Change in different blood pressure measurement2 yearsDifferences in workplace blood pressure, daytime ambulatory blood pressure, home blood pressure and 24-hour ambulatory blood pressure
The distribution of heart rate in young and middle-aged subjects2 yearsThe distribution of heart rate in young and middle-aged subjects who were diagnosed with hypertension
Progression of target organ damage2 yearsDifferences in the progression of target organ damage between controlled or uncontrolled subjects or between subjects with fast and slow heart rate
The development of with-coat hypertension2 yearsThe development of white-coat hypertension as persistent hypertension and other types of hypertension or normal blood pressure and changes in target organ damage
The proportion of masked hypertension in patients with normal high blood pressure2 yearsThe proportion of masked hypertension in patients with normal high blood pressure and the change in outcome after treatment intervention and changes in target organ damage

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026